BioSyent Inc. (BIOYF)
OTCMKTS · Delayed Price · Currency is USD
8.21
0.00 (0.00%)
Oct 28, 2024, 4:00 PM EDT

BioSyent Statistics

Total Valuation

BioSyent has a market cap or net worth of 95.31 million. The enterprise value is 83.61 million.

Market Cap 95.31M
Enterprise Value 83.61M

Important Dates

The next estimated earnings date is Friday, November 15, 2024.

Earnings Date Nov 15, 2024
Ex-Dividend Date Sep 4, 2024

Share Statistics

Shares Outstanding n/a
Shares Change (YoY) -3.48%
Shares Change (QoQ) -0.64%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 8.99M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.37, with an EV/FCF ratio of 46.49.

EV / Earnings 16.00
EV / Sales 3.44
EV / EBITDA 13.37
EV / EBIT 13.96
EV / FCF 46.49

Financial Position

The company has a current ratio of 6.13, with a Debt / Equity ratio of 0.03.

Current Ratio 6.13
Quick Ratio 4.72
Debt / Equity 0.03
Debt / EBITDA 0.13
Debt / FCF 0.46
Interest Coverage 130.27

Financial Efficiency

Return on equity (ROE) is 20.88% and return on invested capital (ROIC) is 14.68%.

Return on Equity (ROE) 20.88%
Return on Assets (ROA) 12.86%
Return on Capital (ROIC) 14.68%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.84
Inventory Turnover 1.34

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +41.07% in the last 52 weeks. The beta is 0.93, so BioSyent's price volatility has been similar to the market average.

Beta (5Y) 0.93
52-Week Price Change +41.07%
50-Day Moving Average 7.92
200-Day Moving Average 7.00
Relative Strength Index (RSI) 58.98
Average Volume (20 Days) 1,768

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BioSyent had revenue of 24.71 million and earned 5.22 million in profits. Earnings per share was 0.44.

Revenue 24.71M
Gross Profit 19.71M
Operating Income 6.09M
Pretax Income 6.92M
Net Income 5.22M
EBITDA 6.26M
EBIT 6.09M
Earnings Per Share (EPS) 0.44
Full Income Statement

Balance Sheet

The company has 12.72 million in cash and 825,934 in debt, giving a net cash position of 11.89 million.

Cash & Cash Equivalents 12.72M
Total Debt 825,934
Net Cash 11.89M
Net Cash Per Share n/a
Equity (Book Value) 25.88M
Book Value Per Share 2.23
Working Capital 18.41M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.85 million and capital expenditures -48,765, giving a free cash flow of 1.80 million.

Operating Cash Flow 1.85M
Capital Expenditures -48,765
Free Cash Flow 1.80M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 79.77%, with operating and profit margins of 24.63% and 21.14%.

Gross Margin 79.77%
Operating Margin 24.63%
Pretax Margin 28.01%
Profit Margin 21.14%
EBITDA Margin 25.34%
EBIT Margin 24.63%
FCF Margin 7.28%

Dividends & Yields

This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 1.62%.

Dividend Per Share 0.13
Dividend Yield 1.62%
Dividend Growth (YoY) 9.22%
Years of Dividend Growth 2
Payout Ratio 27.84%
Buyback Yield 3.48%
Shareholder Yield 5.10%
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BioSyent has an Altman Z-Score of 12.96.

Altman Z-Score 12.96
Piotroski F-Score n/a